12 slides from Adams Respiratory Therapeutics's earnings presentation, Nov 8, 2007
Slide 1: Fiscal 2008 First Quarter Earnings Results
Fiscal 2008 First Quarter Earnings Results November 8, 2007
Slide 2: Safe Harbor
Safe Harbor This presentation contains certain "forward-looking" statements. These statements are based on the current estimates and assumptions of the management of Adams Respiratory Therapeutics, Inc. (or "Adams") as of the date of this presentation and are naturally subject to uncertainty and cha
Slide 4: Fiscal 2008 First Quarter Net Sales by Product
$45.5 $33.9 $10.1 $9.9 $7.3 $3.3 Fiscal 2008 First Quarter Net Sales by Product (in millions) $110.0 Total Net Sales Maximum Strength Mucinex(r) represented 23% of the total oral-solid adult Mucinex franchise sales
Slide 7: New Grape Delsym Achieves High Acceptance Levels
New Grape Delsym(r) Achieves High Acceptance Levels Of the 115 customers we track: Over 90% accepted at least one SKU Over 65% accepted 2 SKUs
Slide 8: Improved Retail Distribution
Improved Retail Distribution Costco(r) Wholesale Stocking Mucinex SE Mucinex DM Delsym Pallet displays in top 200 stores
Slide 9: 12-Hour Relief Center Display Support
12-Hour Relief Center Display Support Visible at a major drug chain 5,000+ stores Starts early November for 9 weeks Pharmacy countertop Buy 2, Get $5.00 in Register Rewards
Slide 10: Adams' Brands At Retail
Adams' Brands At Retail
Slide 11: Mucinex and Delsym Dollar Share Increases
Mucinex and Delsym Dollar Share Increases Source: Information Resources, Inc. U.S. Food/Drug/Mass for the four weeks ended 10/7/07. 10.7 8.9 7.3 6.3 $ Share of Cough/Congestion Liquids Segment
Slide 12: Fiscal 2008 First Quarter Earnings Results
Fiscal 2008 First Quarter Earnings Results November 8, 2007
Source: SEC EDGAR · 8-K filed Nov 8, 2007
More decks from Adams Respiratory Therapeutics Inc